MedDeviceGuideMedDeviceGuide

Medical Device & IVD Blog

EU MDR / IVDR

EU MDR Article 97 Derogations: Legacy Device Contingency Playbook

Comprehensive guide to EU MDR Article 97 derogations, including MDCG 2022-18, Addendum 1 restrictions, national competent authority processes, and contingency planning.

Reimbursement & Market Access

Medicare Advantage Prior Authorization for Medical Devices: Navigating the 2026 Rules

A comprehensive guide to Medicare Advantage prior authorization for medical devices. Learn about CMS-0057-F timelines, CY2026 rules, denial rates, and appeal strategies.

Regulatory

Aesthetic Medical Device Adverse Events and Recalls: A MAUDE Data Analysis

A data-driven analysis of FDA MAUDE adverse events and recalls across aesthetic device classes, analyzing breast implants, lasers, dermal fillers, and cryolipolysis systems.

Regulatory

FDA Safer Technologies Program (STeP) for Medical Devices: Complete Regulatory Guide

A comprehensive guide to the FDA Safer Technologies Program (STeP) in 2026, including eligibility criteria, safety-innovation factors, Q-Submission application steps, benefits, and TAP pilot updates.

Regulatory

Medicare Coverage with Evidence Development (CED) for Medical Devices

A comprehensive guide to Medicare Coverage with Evidence Development (CED) in 2026, mapping active device NCDs, study and registry requirements, and the graduation timeline.

Reimbursement & Market Access

Bundled Payments for Medical Devices: BPCI-Advanced, CJR & Implant Pricing

A strategic playbook for medical device companies navigating CMS bundled payment models (BPCI-Advanced, CJR). Dissects implant pricing and NTAP/OPPS exclusions.

Clinical Evidence

FDA Early Feasibility Studies (EFS): The Strategic Playbook for Novel Medical Devices

A comprehensive guide to the FDA Early Feasibility Studies (EFS) Program for medical devices. Dissects EFS IDE protocols, risk mitigation, and OHT routing.

Reimbursement & Market Access

Outcomes-Based & Value-Based Contracts for Medical Devices: Commercial Playbook

A comprehensive guide to structuring outcomes-based and value-based contracts for medical devices. Analyzes OIG safe harbors, Stark Law, metrics, and case studies.

Regulatory

Certificate of Need (CON) for Medical Devices: State-by-State Guide

State-by-state guide to Certificate of Need (CON) rules for capital medical devices. Map reviewable equipment, thresholds, and sales strategy.

Regulatory

FDA AI-Enabled Medical Device Guidance: Transparency, Labeling & GMLP

Guide to FDA AI medical device rules. Map GMLP, June 2024 transparency, and January 2025 draft guidance to submission and labeling artifacts.

Regulatory

FDA Import Alerts & DWPE for Medical Devices: The Border Gate

Guide to FDA Import Alerts and Detention Without Physical Examination (DWPE) for medical devices. Learn the Red List removal and petition workflow.

Commercialization

Hospital Value Analysis Committees and GPOs: How US Medical Devices Get Bought

Playbook on US hospital Value Analysis Committees (VAC) and Group Purchasing Organizations (GPOs). Explains evaluation rubrics and contracting pathways.

Reimbursement & Market Access

HEOR and the Global Value Dossier: Building Device Evidence That Wins Reimbursement

A guide to HEOR and Global Value Dossier strategy for medical devices. Dissects device-specific economic modeling and payer evidence requirements.

Regulatory

Panama Medical Device Registration: The DNDM Law 90 Compliance Guide

A comprehensive regulatory guide to medical device registration and licensing in Panama under DNDM, Law 90, Executive Decree 490, and Law 419.

Commercialization

Aesthetic Device Market Structure: FDA 510(k) and PMA Approvals Analysis

A data-driven map of the US aesthetic medical device market, analyzing 510(k) energy devices, the laser oligopoly, PMA implants (dermal fillers and breast implants), and recalls.

Policy & Legislation

EU PFAS Restriction for Medical Devices: REACH Timelines and Derogations

How the EU REACH PFAS restriction affects medical device components, key transition timelines (5- and 12-year derogations), concentration limits, and substitution roadmaps.

Quality Systems

SPC for Medical Devices: Cpk/Ppk Targets, Gauge R&R, and Process Validation

A quality engineering guide to statistical process control (SPC) and process capability (Cpk/Ppk) for medical device process validation, including Gauge R&R and FDA QMSR compliance.

Regulatory

Burundi Essential Medical Devices List Teardown: ABREMA 2025

A data-driven teardown of Burundi's National Essential Medical Devices List (2025). Analyze the risk-class split, clinical-service mix, WHO-style tomes, and ABREMA legal framework.

Regulatory

Malawi PMRA Medical Device Register Teardown: Supplier Landscape

A data-driven teardown of Malawi's PMRA Medical Device Register. Analyze the supplier landscape, geographic concentration, registration timeline, and PMRA legal framework.

Regulatory

Mongolia Diagnostic & IVD Device Register Teardown: 2024 LMMD Reset

A data-driven teardown of Mongolia's diagnostic and IVD register. Analyze the risk-class split, country-of-origin mix, top manufacturers, and 2024 LMMD regulatory reset.